Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Consensus Recommendation of “Buy” from Brokerages
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has earned a consensus rating of “Buy” from the fifteen ratings firms that are covering the stock, MarketBeat Ratings reports. Fifteen equities research analysts have rated the stock with a buy rating. The average twelve-month target price among analysts that have updated their coverage on the stock […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has earned a consensus rating of “Buy” from the fifteen ratings firms that are covering the stock, MarketBeat Ratings reports. Fifteen equities research analysts have rated the stock with a buy rating. The average twelve-month target price among analysts that have updated their coverage on the stock […]
